Literature DB >> 21272792

Effective management in clusters of pneumococcal disease: a systematic review.

Marina Basarab1, Chikwe Ihekweazu, Robert George, Richard Pebody.   

Abstract

Outbreaks of serious pneumococcal disease can occur with high attack rates in certain settings. We systematically reviewed studies of interventions implemented in pneumococcal clusters and those reporting the effect of antibiotics on carriage reduction to assess the effectiveness of interventions. Evidence was graded according to the Scottish Intercollegiate Guidelines Network system. Of 28 identified cluster reports, one showed that administration of antibiotics to close contacts reduced risk of pneumococcal disease. In three of four clusters where rifampicin chemoprophylaxis was used and in four of five clusters where penicillin was used no further cases were seen after intervention. In clusters where pneumococcal polysaccharide vaccine was used, subsequent cases occurred, all within around 2 weeks of vaccination, which suggests delayed benefit with this approach (evidence grade D). Use of infection control measures alone was reported in eight clusters, with no further cases being reported in seven (grade D). From 21 selected carriage studies, large carriage reductions were observed consistently with use of penicillin and azithromycin, with median values being 90% and 73%, respectively (grade C). The findings were presented to a working group for pneumococcal cluster guidelines and used to develop key recommendations on the management of clusters that supported prompt use of amoxicillin or azithromycin chemoprophylaxis, pneumococcal vaccination for close contacts, and implementation of infection control measures.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272792     DOI: 10.1016/S1473-3099(10)70281-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  7 in total

1.  Molecular characterization of Streptococcus pneumoniae serotype 12F isolates associated with rural community outbreaks in Alaska.

Authors:  Tammy Zulz; Jay D Wenger; Karen Rudolph; D Ashley Robinson; Alexey V Rakov; Dana Bruden; Rosalyn J Singleton; Michael G Bruce; Thomas W Hennessy
Journal:  J Clin Microbiol       Date:  2013-02-13       Impact factor: 5.948

2.  Persistence and complex evolution of fluoroquinolone-resistant Streptococcus pneumoniae clone.

Authors:  Debby Ben-David; Mitchell J Schwaber; Amos Adler; Samira Masarwa; Rotem Edgar; Shiri Navon-Venezia; David Schwartz; Nurith Porat; Tali Kotlovsky; Nikolay Polivkin; Irina Weinberg; Avraham Lazary; Nissim Ohana; Ron Dagan
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

Review 3.  Streptococcus pneumoniae outbreaks and implications for transmission and control: a systematic review.

Authors:  Paul N Zivich; John D Grabenstein; Sylvia I Becker-Dreps; David J Weber
Journal:  Pneumonia (Nathan)       Date:  2018-11-05

4.  Bacterial Isolates from CSF Samples and Their Antimicrobial Resistance Patterns Among Children Under Five Suspected to Have Meningitis in Dilla University Referral Hospital.

Authors:  Ephrem Awulachew; Kuma Diriba; Netsanet Awoke
Journal:  Infect Drug Resist       Date:  2020-11-23       Impact factor: 4.003

5.  Antimicrobial Resistance Pattern of Bacterial Meningitis Among Patients in Quetta, Pakistan.

Authors:  Syeda Ayesha Ali; Muhammad Kamran Taj; Syeda Hafsa Ali
Journal:  Infect Drug Resist       Date:  2021-12-01       Impact factor: 4.003

6.  Investigation of Concurrent Pneumococcal Meningitis in Two Children Attending the Same Day-Care Center.

Authors:  Alexis Rybak; Emmanuelle Varon; Elodie Masson; Anne Etchevers; Daniel Levy-Brühl; Naïm Ouldali; Corinne Levy; Robert Cohen
Journal:  Front Pediatr       Date:  2022-07-14       Impact factor: 3.569

7.  Streptococcus pneumoniae serotype 15A in psychiatric unit, Rhode Island, USA, 2010-2011.

Authors:  Katherine Fleming-Dutra; Chukwuma Mbaeyi; Ruth Link-Gelles; Nicole Alexander; Alice Guh; Elizabeth Forbes; Bernard Beall; Jonas M Winchell; Maria da Gloria Carvalho; Fabiana Pimenta; Maja Kodani; Cindy Vanner; Hilary Stevens; Diane Brady; Mardea Caulcrick-Grimes; Utpala Bandy; Matthew R Moore
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.